Literature DB >> 21498570

DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.

Larisa Litovchick1, Laurence A Florens, Selene K Swanson, Michael P Washburn, James A DeCaprio.   

Abstract

In the absence of growth signals, cells exit the cell cycle and enter into G0 or quiescence. Alternatively, cells enter senescence in response to inappropriate growth signals such as oncogene expression. The molecular mechanisms required for cell cycle exit into quiescence or senescence are poorly understood. The DREAM (DP, RB [retinoblastoma], E2F, and MuvB) complex represses cell cycle-dependent genes during quiescence. DREAM contains p130, E2F4, DP1, and a stable core complex of five MuvB-like proteins: LIN9, LIN37, LIN52, LIN54, and RBBP4. In mammalian cells, the MuvB core dissociates from p130 upon entry into the cell cycle and binds to BMYB during S phase to activate the transcription of genes expressed late in the cell cycle. We used mass spectroscopic analysis to identify phosphorylation sites that regulate the switch of the MuvB core from BMYB to DREAM. Here we report that DYRK1A can specifically phosphorylate LIN52 on serine residue 28, and that this phosphorylation is required for DREAM assembly. Inhibiting DYRK1A activity or point mutation of LIN52 disrupts DREAM assembly and reduces the ability of cells to enter quiescence or undergo Ras-induced senescence. These data reveal an important role for DYRK1A in the regulation of DREAM activity and entry into quiescence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498570      PMCID: PMC3078706          DOI: 10.1101/gad.2034211

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

1.  Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

Authors:  Y Takahashi; J B Rayman; B D Dynlacht
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

2.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

Authors:  Katrin Tschöp; Andrew R Conery; Larisa Litovchick; James A Decaprio; Jeffrey Settleman; Ed Harlow; Nicholas Dyson
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

Review 3.  Cell-cycle control in Caenorhabditis elegans: how the worm moves from G1 to S.

Authors:  John Koreth; Sander van den Heuvel
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

4.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

Review 5.  The retinoblastoma gene family in cell cycle regulation and suppression of tumorigenesis.

Authors:  Jan-Hermen Dannenberg; Hein P J te Riele
Journal:  Results Probl Cell Differ       Date:  2006

6.  Mip/LIN-9 regulates the expression of B-Myb and the induction of cyclin A, cyclin B, and CDK1.

Authors:  Mark Pilkinton; Raudel Sandoval; Julie Song; Scott A Ness; Oscar R Colamonici
Journal:  J Biol Chem       Date:  2006-11-10       Impact factor: 5.157

Review 7.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

8.  Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Authors:  Jan-Hermen Dannenberg; Leontine Schuijff; Marleen Dekker; Martin van der Valk; Hein te Riele
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

Review 9.  Function and regulation of Dyrk1A: towards understanding Down syndrome.

Authors:  Joongkyu Park; Woo-Joo Song; Kwang Chul Chung
Journal:  Cell Mol Life Sci       Date:  2009-08-14       Impact factor: 9.261

10.  Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice.

Authors:  Vassiliki Fotaki; Mara Dierssen; Soledad Alcántara; Salvador Martínez; Eulàlia Martí; Caty Casas; Joana Visa; Eduardo Soriano; Xavier Estivill; Maria L Arbonés
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more
  132 in total

1.  The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression.

Authors:  Subhashini Sadasivam; Shenghua Duan; James A DeCaprio
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

2.  Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.

Authors:  Lillian Seu; Steffanie Sabbaj; Alexandra Duverger; Frederic Wagner; Joshua C Anderson; Elizabeth Davies; Frank Wolschendorf; Christopher D Willey; Michael S Saag; Paul Goepfert; Olaf Kutsch
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

3.  A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

Authors:  Katrin Tschöp; Andrew R Conery; Larisa Litovchick; James A Decaprio; Jeffrey Settleman; Ed Harlow; Nicholas Dyson
Journal:  Genes Dev       Date:  2011-04-15       Impact factor: 11.361

4.  Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.

Authors:  I D Tonks; P Mukhopadhyay; W A Schroder; A Sorolla; A W Mould; H Y Handoko; B Ferguson; H K Muller; P Keith; N K Hayward; G J Walker; G F Kay
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

5.  Sweet DREAMs for Hippo.

Authors:  Frederick A Dick; Joe S Mymryk
Journal:  Genes Dev       Date:  2011-05-01       Impact factor: 11.361

Review 6.  The potential of targeting Sin3B and its associated complexes for cancer therapy.

Authors:  David J Cantor; Gregory David
Journal:  Expert Opin Ther Targets       Date:  2017-10-09       Impact factor: 6.902

7.  Structural mechanism of Myb-MuvB assembly.

Authors:  Keelan Z Guiley; Audra N Iness; Siddharth Saini; Sarvind Tripathi; Joseph S Lipsick; Larisa Litovchick; Seth M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

8.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

Review 9.  Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers.

Authors:  Gregory David
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

10.  Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways.

Authors:  Jongchan Kim; Ashley N Siverly; Dahu Chen; Min Wang; Yuan Yuan; Yumeng Wang; Hyemin Lee; Jinsong Zhang; William J Muller; Han Liang; Boyi Gan; Xianbin Yang; Yutong Sun; M James You; Li Ma
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.